Investment6 Nov 2025, 04:36 pm
GlaxoSmithKline Pharmaceuticals Ltd Approves Investment in Solar Power Project
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has approved an investment of Rs. 1.74 crores for a Solar Power project for its plant at Nashik. The investment is aimed at meeting the company's green energy needs, optimizing energy costs, and complying with regulatory requirements. The project is expected to be completed within 180 days.
Key Highlights
- Investment of Rs. 1.74 crores approved for Solar Power project
- Project aims to meet green energy needs and comply with regulatory requirements
- Expected to be completed within 180 days
- Investment is in a special purpose vehicle (SPV) named Clean Max Galapagos Private Limited
- Clean Max Galapagos Private Limited to supply 4.95 MWp capacity to GlaxoSmithKline Pharmaceuticals Limited